Advisory Board

Our experts are highly respected authorities in the biosimilars and healthcare industries, including health economics experts, pharmacists, managed care professionals, and key clinical specialists. We are the authoritative resource for emerging therapies.

Ivo Abraham, PhD, RN
Director, Center for Health Outcomes and PharmacoEconomic Research
The University of Arizona Cancer Center
Joseph P. Fuhr, Jr., PhD
Professor Emeritus
Widener University
Christy M. Gamble, JD, DrPH, MPH
Director of Budget and Policy Advocacy, American Public Human Services Association
Julie M. Kennerly-Shah, PharmD, MS, MHA, BCPS
Assistant Director
The James Cancer Hospital
The Ohio State University Medical Center
Jim M. Koeller, MS
Eli Lilly & C.R. Sublett Fellow
Professor of Pharmacotherapy
Pharmacotherapy Education & Research Center
University of Texas Health Science Center San Antonio
Molly Billstein Leber, PharmD, BCPS, FASHP
Manager
Medication Policy and Formulary Management
Yale New Haven Health System
Brian Lehman, MBA, MHA, RPh
Director
Medical Account Management and Strategic Alliances
Sandoz
Rick Lozano
Vice President
Biosimilars and Integrated Business Development
AmerisourceBergen
Steven Lucio, PharmD, BCPS
Associate Vice President
Clinical Solutions and Pharmacy Program Development
Vizient
Julie Marechal-Jamil
Director
Biosimilars Policy and Science
Medicines for Europe
Ali McBride, PharmD, MS, BCPS
Clinical Coordinator Hematology/Oncology
The University of Arizona Cancer Center
Sonia T. Oskouei, PharmD
Vice President, Innovation and Solution Development
Premier Inc
Kashyap Patel, MD
Medical Oncologist
Carolina Blood and Cancer Care
Leigh Purvis, MPA
Director, Health Services Research
AARP Public Policy Institute
Hope Rugo, MD
Clinical Professor
Department of Medicine (Hematology/Oncology)
Director
Breast Oncology Clinical Trials Program
University of California at San Francisco
Kyle F. Skiermont, PharmD
COO
Fairview Pharmacy Services
James G. Stevenson, PharmD, FASHP
Professor
Department of Clinical Pharmacy
University of Michigan College of Pharmacy
Ha Kung Wong, JD
Partner
Fitzpatrick, Cella, Harper & Scinto
Gillian Woollett, MA, DPhil
Senior Vice President
Avalere Health

If you are interested in becoming a contributor and adding your voice to the conversation, contact our Associate Editorial Director or our Senior Editor.

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.